Notably, we observed an increase in the frequency of CD3−CD56+CD38+ NK-cells, which might render NK-cells more susceptible to daratumumab-mediated fratricide – a potentially deleterious off-tumour effect of daratumumab. Here, CD38 is linked to neoplasm.